US 10351618
UTI fusion proteins
granted A61KA61K38/00A61P
Quick answer
US patent 10351618 (UTI fusion proteins) held by Takeda Pharmaceutical Company Limited expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/04